Of all the company's which have managed to generate a large cult like following, perhaps no micro-cap stock has done as good of a job as the .07 cent stem cell company Advanced Cell Technology (ACTC.OB). Since the company's inception in the mid 90's as an animal cloning company, Advanced Cell Technology has managed to dilute its current number of outstanding shares to a whopping 2,560,000,000 since its original IPO. Needless to say, it has not been a profitable ride for long-term shareholders thus far. Rather, it appears that shareholders have been hit time and time again with dilutions, and questionable actions by management, which whether purposeful or accidental, has not reflected well on the company. Interestingly enough however, Advanced...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|